SCHEMBL21864816

SCHEMBL21864816

CC(C)(C)C(=O)Nc1ncc2cc(O)ccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.44
▸ ADORA1 P30542 1/20 0.43
▸ TYR P14679 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ BRAF P15056 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAP3K5 Q99683 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ F2 P00734 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10828998 0.86 KMT2A (0.46) ADORA1PIK3CABRAFPOLBL3MBTL1
SCHEMBL25449359 0.84 ADORA1 (0.43) ADORA1PIK3CABRAFPOLBL3MBTL1
SCHEMBL30216052 0.84 MAPT (0.46) ADORA1PIK3CABRAFPOLBL3MBTL1
SCHEMBL21864813 0.84 MAPT (0.46) ADORA1PIK3CABRAFPOLBL3MBTL1
SCHEMBL21864960 0.77 TYR (0.45) ADORA1TYRL3MBTL1MEN1KMT2A
SCHEMBL21864818 0.76 DGAT1 (0.41) ADORA1PIK3CAPOLBF2
SCHEMBL30161251 0.76 DGAT1 (0.41) ADORA1PIK3CAPOLBF2
SCHEMBL25453515 0.72 PIK3CA (0.34) ADORA1PIK3CABRAFPOLB
SCHEMBL21864812 0.72 AOC3 (0.61) —
SCHEMBL6651265 0.72 ADORA1 (0.48) ADORA1POLBMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063854-A1 QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS 南京明德新药研发有限公司 2020-04-02 — — WO disclosed
Send feedback